NHS Set to Save Millions on Essential Prescribing Software through New Framework

NHS Shared Business ServicesThe NHS will have the opportunity to save millions of pounds on important but traditionally costly IT prescribing systems that help healthcare professionals to choose the correct and most cost effective medicines for patients, following the launch of a new procurement framework from NHS Shared Business Services (NHS SBS).

The new Medicines Management Prescribing Decision Support Systems Framework (MMDSS) is injecting healthy new competition into the market for the widely-used technology. The prescribing systems help doctors, nurses and other clinical staff select the most affordable and appropriate treatments for specific patients. NHS organisations can now choose to purchase either OptimiseRx or ScriptSwitch, without the need to engage in complex and costly individual procurement exercises.

The technology, which is particularly important for patient safety, is now being made available at more competitive rates and with improved contract terms through the shared services framework. The new MMDSS framework was created after five clinical commissioning groups (CCGs) turned to NHS SBS to allow them to approach the market for a more competitive service.

Each CCG from the collaborative across Central London, West London, Hammersmith and Fulham, Hounslow and Ealing, has now secured robust new terms and conditions with their chosen supplier as a result of the procurement work carried out by NHS SBS. This has helped the CCGs negotiate lower prices, without the need to work through the complexities of European procurement regulations, which NHS SBS has completed on their behalf. The result is a saving on software licenses of more than £60,000 per year for the CCGs.

These benefits could now spread quickly across the NHS, as a result of the MMDSS framework that was created by NHS SBS in parallel to the CCG procurements. This means that all NHS prescribing organisations now have a choice of competitive supplier and NHS favourable terms, without the need to run their own individual costly procurement exercises.

Thomas Slater, strategic procurement team, NHS Shared Business Services, said: "This is a great example of a real NHS collaboration that will help the wider NHS make significant savings on an important technology needed across the country.

"The five CCGs we have worked with are already reaping the benefits of supplier choice. Now the newly launched Medicines Management Prescribing Decision Support Systems Framework will allow the wider NHS to achieve better prices, terms and greater choice from the market in the same way, without the need to conduct their own time consuming and expensive competitions."

Following a robust selection process led by clinical, prescribing and pharmaceutical specialists, NHS organisations are now able to choose to purchase OptimiseRx, supplied by First Databank Europe Ltd, or ScriptSwitch, supplied by Optum Health Solutions, through the framework, without the need to navigate OJEU procurement rules.

Medicines management prescribing decision support technology is providing NHS organisations with the ability to make major savings by choosing cost-effective treatments.

The new framework agreement will also offer centralised and remote management of the profile of switch suggestions to deliver improved accuracy, visibility and consistency when prescribing. Linked with other systems, the technology makes suggestions and enables prescribers to switch easily to the suggested medicine, at an appropriate dose and frequency, if the switch suggestion is accepted.

The new framework for the technology is now open to organisations across the NHS, for further information please contact Caroline Wright on 0161 212 3721.

About NHS SBS
NHS Shared Business Services (NHS SBS) is the market leader in business support services for the NHS. It provides finance and accounting, employment services, procurement and primary care services, delivering operational efficiencies and improved service quality as well as real cost savings, on average 30%, for its NHS clients. Established in 2005, NHS SBS is a 50/50 joint venture between the Department of Health and Sopra Steria Limited. The organisation now provides financial services to 100% of all NHS commissioning organisations and a range of business support services for around 50% of NHS provider trusts.

NHS SBS currently employs over 1,750 people who bring a unique mix of NHS and commercial expertise. They process over £170 billion of NHS payments each year and pay 390,000 NHS employees. The organisation has also identified more than £350 million procurement savings opportunities. NHS SBS is on-course to achieve £1 billion of cost savings to the NHS by 2020, having achieved its original 10-year target of £224 million of cost savings, a year earlier than planned in 2014.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...